Institute Group Leaders awarded promotions in the University
We are delighted to announce that two of our Senior Group Leaders, Jason Carroll and Masashi Narita, have been promoted to professors in this years’ round of Senior Academic Promotions.
Both have been assigned to the Department of Oncology, where their professorships will take effect from 1 October 2019. They join 41 other world-leading researchers who have been promoted to professors across the University of Cambridge.
Jason Carroll has been promoted to Professor of Molecular Oncology. Carroll’s research at the Institute focuses on the oestrogen receptor, which switches on genes in breast cancer cells causing the cells to grow. By understanding how the oestrogen receptor switches genes on and how drugs like tamoxifen work to switch them off, the team hope to learn more about how cancers develop resistance to these drugs. This information can help to make better and more effective drugs for cancer treatments.
Masashi Narita has been promoted to the position of Professor of Senobiology. Narita’s team are studying how to permanently stop the growth of tumour cells. In response to internal and external stresses, cells can choose to either die or to stop cell division permanently in order to remove unhealthy cells. Permanently stopping cell growth causes many changes in cells, affecting gene expression and how proteins are processed within the cell. By understanding the mechanisms of these changes, the Narita Group are working to provide new and alternative tools to tackle cancers.
Related News
See all news-
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
6th December 2024
An MRI-based imaging technique developed at the Institute predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Find out more -
Isabel Esain Garcia awarded PhD Thesis Prize
3rd December 2024
The Prize is awarded annually to a student who has undertaken an outstanding research project to the highest standards during the course of their PhD study at the Cancer Research UK Cambridge Institute.
Find out more -
World first trial to revolutionise treatment of brain cancer
23rd October 2024
A pioneering research study will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer.
Find out more